ArticlePDF Available

An HPLC Method for detection of Anti-inflammatory Drugs in Bone and Cartilage health supplements

Authors:

Abstract and Figures

Many bone-building and cartilage repair supplements are available in the market and, many people especially the elderly people use these supplements. Manufacturers claim various therapeutic properties for these types of supplements. Therefore, it is likely that these products are included with chemical and anti-inflammatory drugs that are not listed in labels and brochures. There is not reported using HPLC method to check for chemical and anti-inflammatory drugs in bone and cartilage supplements, by the competent authorities. In this research, a valid, simple, affordable and selective method launched to quantify and identify some corticosteroids in bone and cartilage supplements. This method involves the extraction of the case from supplements using ethanol and injection directly to high-performance liquid chromatography (HPLC). The effect of different variables such as mobile phase, column type, pH and other variables was investigated. Optimum conditions including water-acetonitrile mobile phase with a ratio of 55:45, ODS column, column temperature of 25°C, injection volume of 20 microliters, detector wavelength of 254 nm and the mobile phase flow rate 1ml/min were obtained. With this HPLC analysis method, cartilage repair products and bone-building supplements can be simply analyzed and the proportion of infected or free corticosteroids can also be identified.
Content may be subject to copyright.
Asian Journal of Pharmaceutical Analysis. 10(2): April- June, 2020
67
ISSN 22315667 (Print)
22315675 (Online)
DOI: 10.5958/2231-5675.2020.00012.5
Vol. 10 | Issue-02|
April- June | 2020
Available online at
www.anvpublication.org
www.asianpharmaonline.org
Asian Journal of Pharmaceutical Analysis
Home page www. ajpaonline.com
RESEARCH ARTICLE
An HPLC Method for detection of Anti-inflammatory Drugs in Bone and
Cartilage health supplements
Sevil Banay Razi1, Farzaaneh Zaaeri2, Hamid Akbari Javar2*
1Department of Drug Quality Assurance, Faculty of Pharmacy, Pharmaceutical Sciences Branch,
Islamic Azad University, Tehran, Iran.
2Department of Pharmaceutics, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.
*Corresponding Author E-mail: akbarijo@tums.ac.ir
ABSTRACT:
Many bone-building and cartilage repair supplements are available in the market and, many people especially the
elderly people use these supplements. Manufacturers claim various therapeutic properties for these types of
supplements. Therefore, it is likely that these products are included with chemical and anti-inflammatory drugs
that are not listed in labels and brochures. There is not reported using HPLC method to check for chemical and
anti-inflammatory drugs in bone and cartilage supplements, by the competent authorities. In this research, a
valid, simple, affordable and selective method launched to quantify and identify some corticosteroids in bone
and cartilage supplements. This method involves the extraction of the case from supplements using ethanol and
injection directly to high-performance liquid chromatography (HPLC). The effect of different variables such as
mobile phase, column type, pH and other variables was investigated. Optimum conditions including water-
acetonitrile mobile phase with a ratio of 55:45, ODS column, column temperature of 25°C, injection volume of
20 microliters, detector wavelength of 254 nm and the mobile phase flow rate 1ml/min were obtained. With this
HPLC analysis method, cartilage repair products and bone-building supplements can be simply analyzed and the
proportion of infected or free corticosteroids can also be identified.
KEYWORDS: Cartilage repair supplement, Bone-building supplement, corticosteroids, HPLC analysis,
prednisolone, hydrocortisone
INTRODUCTION:
Many bone and cartilage repair supplements are sold in
the market and, elderly people use for improvements in
their bones and cartilages. Producers claim many
therapeutic advantages for these products such as fast
recovery of bone and cartilage. Hence, there is an
uncertainty of prohibited anti-inflammatory and
chemical drugs that are included in products but not
mentioned in labeling.
Received on 12.10.2019 Accepted on 19.11.2019
Accepted on 28.12.2019 ©Asian Pharma Press All Right Reserved
Asian J. Pharm. Ana. 2020; 10(2):67-76.
DOI: 10.5958/2231-5675.2020.00012.5
Food supplements are used for delivery of some essential
food ingredients that are not provided by usual food
regimens. Supplements generally contain vitamins,
minerals, fiber, fatty acids and aminoacids. Food and
Drug Administration (FDA) defines food supplements as
food, although they may be classified as drug or other
products. More than 50,000 kinds of food supplements
are available around the world. More than half of adults
in the united states usually use food supplements
especially multi vitamins[1].
Most of the supplements in the market that claim
fortification and recovery of bones and cartilages or
joints pain reduction, contain Glucosamine and
Asian Journal of Pharmaceutical Analysis. 10(2): April- June, 2020
68
Chondroitin, minerals containing calcium, magnesium,
manganese, zinc, copper, phosphorus, vitamins D, C, K
and fatty acids such as Omega 3. Many elderly people
certified that their pain has decreased after using these
supplements. Therefore, there is a high possibility of
some chemical substances and anti inflammatory drugs
such as corticosteroids to be included in the composition
of these supplements[1 4].
Corticosteroids are a group of hormones that act against
inflammation in the body and have anti-inflammatory
properties. These hormones suppress the immune system
to reduce inflammation and pain[2,5]. A lot of drugs based
on endogenous corticosteroids with similar structure and
pharmaceutical action have been built and widely used in
allergy, autoimmune diseases and inflammation.
Examples include betamethasone, dexamethasone,
hydrocortisone, triamcinolone, methyl prednisolone,
prednisone, fludrocortisone, fluticasone, and so on.
These drugs are produced and consumed in the form of
injections, oral drops, ointments and nasal sprays.
Corticosteroid medications are mostly given in the
higher value than the normal amount in the body. Higher
concentrations of these compounds have potent anti-
inflammatory effects and alleviate symptoms of arthritis,
asthma and inflammatory bowel disease[2 7].
Longtime usage of these pharmaceuticals may increase
blood sugar in susceptible people and leads to
Diabetes[8]. Osteoporosis is a well-known side effect of
long time administration of corticosteroids[9]. Depression
and high blood pressure are other complications. When
patients use corticosteroids, adrenal glands decrease or
stop natural cortisol secretion levels. Therefore,
corticosteroids have many adverse side effects such as
the accession of depression, hallucinations, mania and
manic attacks as well as mental disorders[2]. The effect
on the body's fluid balance and electrolytes, leads to salt
and water retention in the body and ultimately edema[8].
The effect on fat distribution results in the subsequent
accumulation of fat in certain areas of the body such as
back and neck[10]. High blood pressure, high blood
glucose (hyperglycemia), diabetes and hyperlipidemia,
are known as strong factors for cardiovascular disease
and heart attacks[11]. Bone loss and osteoporosis, as well
as rupture or tendon damage in high doses are other side
effects[9,12]. Reduced and weakened layers of the
gastrointestinal mucosa, especially gastric ulcers are
caused and exacerbated[13]. Intraocular high pressure,
glaucoma and cataract are also observed[14]. Therefore,
corticosteroids are usually medicated in combinations
with other safer drugs or as prodrugs in order to release
drugs only near the target site, so that mentioned side
effects are decreased[15 17].
Products that include combinations of Glucosamine and
Chondroitin make effective help in the treatment of pain
in arthritis. Other applications including the treatment of
rheumatoid arthritis and osteoporosis have not been
proven by research[18]. In the early 1980s, in a cross-
sectional study, 30 hospitalized patients with knee
osteoarthritis were randomized to use placebo, a
combination anti-arthritic medication or glucosamine
sulfate 1500mg daily for three weeks. The group that
received treatment with glucosamine sulfate showed
significant improvements in pain, joint tenderness and
edema, whereas in the control group, there were no such
improvements[19]. The medicinal use of these products is
not approved by FDA (Food and Drug Administration)
and doctors are not allowed to prescribe people as a
medication. Glucosamine and Chondroitinare are often
sold in drug stores as an herbal supplement although
there are no production standards for their preparation as
plant products. Some of these supplements are
containing toxic metals and chemical drugs[20].
The existence of corticosteroids and chemical agents in
food supplements is contrary to regulations of the WHO
(World Health Organization). Accordingly, development
of a method to identify chemical drugs and the quality of
cartilage maker and bone-building supplements is
necessary.
A number of studies have been conducted to evaluate
and analyze combinations of corticosteroids in different
samples such as medications, hair, plasma, urine and
food.UV spectrophotometry, HPTLC (High performance
Thin Layer Chromatography) and HPLC (High
performance Liquid Chromatography) methods have
been used for analysis of corticosteroids[21,22]. Some of
different methods are listed in table 1.
Table1.Example studies in the field of analysis of corticosteroids.
Reference
Sample
Instrument/Method
Study
[23]
human urine
GS / MS extraction by n- pentane
and MSTFA* / NH4I /
Ethanethiol
Identifying and measurement of
anabolic steroids in dietary
supplements
[24]
human plasma
LCMS/MS extraction by
acetonitrile: water: formic acid
(32:68:0.1, v/v/v)
Quantitative analysis of cortisol,
cortisone, prednisolone and
prednisone in human plasma
[25]
human urine
LC-MS / MS extraction by 0.1%
acetic acid in water and
acetonitrile
Detection of corticosteroids,
anabolic steroids and ß2-Agonist
during Athens 2004 olympic games
Asian Journal of Pharmaceutical Analysis. 10(2): April- June, 2020
69
[26]
human urine
LC-MS / MS extraction by water,
ammonium formate, acetonitrile
with formic acid (0.01%)
Detection and characterization of
prednisolone metabolites in human
urine
[27]
human plasma
LC-MS / MS extraction by
10 mM ammonium formate
buffer and acetonitrile (35:65,
v/v)
Assay of methylprednisolone in
human plasma and its
pharmacokinetic application
[28]
human plasma
human urine
human saliva
UHPLC-MS / MS extraction by
ammonium acetate in water and
ammonium acetate in methanol
both with 0.1% formic acid.
Determination of glucocorticoids in
human plasma, urine and saliva
[29]
rat plasma
LCESI MS/MS extraction by
50% water containing 0.01%
formic acid and 50% acetonitrile
A rapid, sensitive and specific
method for the simultaneous
detection of corticosteroids
[30]
human urine
LC-MS / MS extraction by 1 %
Formic acid and acetonitrile
Detection of synthetic
corticosteroids
[31]
human plasma
GCMS derivatization by
heptafluoro-n-butyric anhydride
(HFBA)
Simultaneous determination of
corticosteroids in plasma
*MSTFA: N-methyl-N-trimethyl silyl trifluoro acetamide
**LCESI MS MS: Liquid chromatographyelectrospray-tandem mass spectrometry
As a result of discussed subjects, specification of a
method for identification of anti-inflammatory and
chemical drugs for quality control of bone and cartilage
fortifier supplements is needed. In this study, we aimed
to practice and validate a standard and simple HPLC
method for identification and determination of chemical
unwanted corticosteroids in bone and cartilage
regeneration supplements. We looked for a separation
method based on gas or liquid chromatography followed
by a spectrophotometric method for specification and
identification of the slightly ingredients. We explained a
standard method using the similar articles as well as
international standards in this field.
MATERIAL AND METHODS:
Full experimental work conducted to set up an accurate,
inexpensive and easy method. All the laboratory
analyses done based on standard Prednisone and
Hydrocortisone.
1. Materials and standards:
Standard prednisone and hydrocortisone were obtained
from Iran hormone industries. HPLC grade methanol and
acetonitrile were purchased from Merck. HPLC grade
purified distilled water was used.
2. Instruments:
High-performance liquid chromatography (HPLC)
system manufactured by DIONEX company with a
gradient pump model Ultimate 3000 equipped with
autosampler 100 microliter injection in maximum was
used. There was a separate oven to adjust the
temperature of the column. UV detector model
UVD170U made by company DIONEX, column C18
(ODS= Octadecylsilane) (460 mm × 250 mm) containing
particles with a diameter of 10µm Manufactured by
Thames Resiek company and the software Auto Chrom
2000 for recording chromatograms were used. UV
spectrophotometer model UV-265FW manufactured by
Shimadzu was used for concentrations evaluation.
Digital scale Model B154 Manufactured by Mettler
Toledo company with a precision of 0.1mg, digital scale
manufactured by Shimadzu with a precision of
0.0001mg, ultrasonic bath model 4200 Manufactured by
Solte company, pH meter manufactured by Mettler
Toledo company and centrifuge model D72 made by
Andreas Hettich company were used. Millipore filtration
system with a vacuum pump and water Purification
system model Basic 360 coupled with the Max-ultra 354
Aqua Manufactured by Younglin company were used to
remove particles from solvents and make HPLC grade
water, respectively.
3. Optimization of the extraction method:
To extract corticosteroids from cartilage repair (bone-
building) supplements, we used solvents that dissolve
these compounds as well but not dissolve other
components. In another word, excipients should be
poorly soluble or insoluble in the solvents. We examined
solvents such as methanol, ethanol, acetonitrile, and
chloroform and investigated the extraction process.
Standard hydrocortisone and prednisolone solutions in a
concentration of 10μg/ml were prepared by each HPLC
grade solvent and centrifuged for 10 min. Supernatants
were diluted 10 times with solvents and their absorptions
were determined by UV spectrophotometer. In the
extraction process, choosing an efficient solvent is the
most crucial part of the process because the solvent must
solve goal substance as well but does not solve other
compounds and excipients in the sample matrix. Since
the compounds found in cartilage maker (bone-building)
supplements are dissolved in water, solvents such as
Asian Journal of Pharmaceutical Analysis. 10(2): April- June, 2020
70
acetonitrile, chloroform, methanol and ethanol were
used. In order to achieve the most appropriate solvent,
extraction process was performed and absorption spectra
were provided.
4. Selection of the optimum condition for HPLC
process:
In this study, we aimed to achieve an optimal method of
high-performance liquid chromatography (HPLC) to
identify and quantify the anti-inflammatory compounds
(hydrocortisone and prednisone) in cartilage maker
supplements. According to previous studies to identify
anti-inflammatory compounds by HPLC method, in
order to view the appropriate peak for these compounds,
the mobile phase of water: methanol in a gradient
washing was used and the percentage of mobile phase
portions was changed from 50:50 (water: methanol) to
100% methanol. Other conditions were set as follows:
C18 column with a length of 12.5cm, a diameter of 4.5
mm and particle size of 10 micrometers, UV detector
wavelength of 254nm, flow rate of 1ml/min for mobile
phase, column temperature of 30oC and injection volume
of 20ml. Standard solutions of prednisolone and
hydrocortisone with a concentration of 0.5μg / ml were
prepared and injected[3234]. To achieve a fit peak with
the best area in an HPLC analysis, various parameters
including column, type and percentage of mobile phase,
UV detector wavelength, column temperature, injection
volume and flow rate of mobile phase can be changed[35
38].
To select a proper column, a variety of factors including
properties of substance such as solubility, chemical
nature of the functional groups and molecular weight
should be regarded. It must be examined whether the
species are selectively separable on the stationary phase.
In this study, standard solutions of hydrocortisone and
prednisolone in a concentration of 50μg/ml with C8 and
C18 columns from different companies were studied to
identify anti-inflammatory compounds and acquire the
most appropriate peak. To select a proper column, a
variety of factors including properties of species such as
solubility, the chemical nature of functional groups in
any desired species and molecular weight should be
considered. It must be examined whether the species can
be separated on the selected stationary phase. Chemical
structure of the corticosteroids or anabolic steroids such
as hydrocortisone and prednisone contains a lipophilic
base with four carbon rings and one or more polar
groups resulting being insoluble in water or low soluble.
As a result, column chromatography with C18 stationary
phase and normal phase chromatography are
recommended to identify and isolate them. Columns
have large differences in retention of materials due to the
different construction of active silanol groups.
Mixtures of water and acetonitrile are the most common
mobile phases for liquid chromatography with high
efficiency. Acetonitrile and methanol have different
chromatographic characteristics. Acetonitrile has low
viscosity, low UV absorption, good kinetics which
makes sharper peaks, more efficient washing that leads
to lower consumption of solvent, and less back pressure
for acetonitrile-water mixtures in comparison with
mixtures of methanol-water. Methanol is odorless and
less toxic than acetonitrile which causes better and safer
working conditions. Salts have better solubility in it and
the risk of deposit formation is lower. It is suitable for
isolation of bases in alkaline pH condition. On the other
hand, the polarity of the mobile phase is effective in
separation of species and chromatographic washing. In
reverse phase systems with a non-polar C18 stationary
phase, non-polar species have longer retention times and
their exit time from the column is altered by changing
the ratio of mobile phase. Among three solvents of
water, acetonitrile and methanol, dipole moment in water
is stronger and as a result water has the highest and
methanol has the lowest polarity. But water is not a good
washing solvent for corticosteroids causing delayed
elution, so the percentage of organic solvent should be
increased.
Changes in column temperature cause changes in the
chromatographic parameters (viscosity, kinetics,
efficiency) and chemical or thermodynamic changes
(enthalpy of adsorption, retention time and selectivity).
An increase in temperature from 30°C to 40°C causes
peaks move at different speeds toward the beginning of
the chromatogram and the retention time and selectivity
is slightly reduced but the column pressure is increased.
In this study, standard solutions of hydrocortisone in
concentration of 100μg/ml and prednisolone in
concentration of 20μg/ml were prepared and different
temperatures from 25 to 40°C were applied on the
column. The peaks obtained and the effect of
temperature on the area under the peak and retention
time of samples was analyzed.
Ideal flow rate for this study was considered 1 ml/min.
To confirm method robustness and the optimal flow rate,
flow rates from 0.9 to 1.1ml/min using standard
solutions of hydrocortisone 100μg/ml and prednisone
20μg/ml were applied. Each standard solution was
individually injected three times to the HPLC system and
the effect of flow rate on the retention time and the area
under the peak of standard solutions and control samples
was studied. According to the conducted review on
chromatograms, applying the flow rate of 1/1 ml/ min for
both standard and control samples reduces retention time
of the samples; the sample and the solvent peaks may
interfere, and the area under the peak may show a
decline. While applying a flow rate of 0.9ml/min for
both solutions increases the retention time of the sample
Asian Journal of Pharmaceutical Analysis. 10(2): April- June, 2020
71
there by the sample is removed later and the area under
the peak is also enlarged.
To confirm an appropriate wavelength, wavelengths of
250nm and 260nm using standard solutions were applied
and retention time and area under the peak of each
method were studied.
In order to perform quantitative analysis and
measurement of anti-inflammatory compounds in these
supplements, calibration curves for each compound was
separately plotted. To plot calibration curve of
hydrocortisone, solutions with different concentrations
from 10 to 130μg/ml were prepared and the best
concentration range for plotting the curve was obtained.
The appropriate graph with concentrations in the range
of 70 to 130μg/ml was plotted. 5 solutions at
concentrations of 70, 80, 130, 115, 110μg/ml were
injected into the HPLC system. Each sample was
analyzed three times and a calibration curve was plotted.
To plot calibration curve of prednisolone, solutions with
different concentrations from 1 to 13μg/ml were
prepared and the best concentration range was obtained.
The appropriate graph with concentrations in the range
of 7 to 13μg/ml was plotted. 5 solutions at
concentrations of 7, 9, 10, 12, 13μg/ml were prepared
and injected into the HPLC system. Each sample was
analyzed three times and a calibration curve was plotted.
5. Method Validation:
After the best analysis method was achieved, it should be
validated by the conditions and standard materials.
Validation methods were applied to investigate
validation parameters for evaluation of hydrocortisone
and prednisolone in bone-building and cartilage repair
supplements.Validation factors including selectivity,
linearity, precision, accuracy and limit of detection were
measured[3240].
Linearity within the range of analysis should be
confirmed. Linearity is determined by visual inspection
of calibration curve plotted based on analytical signals
against samples concentrations. After the initial ensuring
linearity of the graph, a closer look should be done by an
appropriate statistical method. To evaluate the linearity
of hydrocortisone analysis method, standard solutions
with concentrations of 70, 85, 90, 100, 110, 115 and
130μg/ml were prepared and each solution was injected
twice into the HPLC system and linearity curve was
plotted. For prednisolone the method was conducted in
the same way, but with different concentrations of 7, 8,
9, 10, 11, 12 and 13μg/ml[35].
Precision of an analysis method indicates the degree of
coordination among the results of separate tests in
condition that multiple samples are taken from a
homogeneous sample. Precision of an analysis method is
usually explained by standard deviation (SD) factor and
relative standard deviation (RSD) that is also stated as
coefficient of variation (CV). Precision may be
illustrated as reproducible precision or reproducibility of
the method of measurement under normal conditions of
analysis. Precision of the analysis method is determined
at two levels. Repeatability was specified by
determination of technique precision in one day, in one
laboratory and by one examiner. This way is also called
Intra-day evaluation of precision. Reproducibility was
elucidated by measurement of precision in different
days, in different laboratories by different devices and
testers which is also called the Inter-day precision.
Precision of the method was carefully specified for
hydrocortisone and prednisolone analysis by HPLC.
The real amount of active ingredient in a pharmaceutical
formulated product is nominated as accuracy. Accuracy
is verified by adding a known amount of substance to the
excipient materials in the range of analysis method
which can be precisely determined. If it is not possible to
provide samples of the excipients, another acceptable
way to determine accuracy is that known amounts of
substance is added to pharmaceutical product and the
results of analysis of substance is compared with the
results of another proposed method that its accuracy has
been proven. Hence for the determination of accuracy of
the method, standard solutions of hydrocortisone with
concentrations of 90 and 110μg/ml and prednisolone
with concentrations of 8 and 11μg/ml were added to the
samples and injected 3 times into the HPLC system. The
recovery for each concentration was calculated and
reported as accuracy.
According to ICH guidelines, signals measured with low
concentrations of certain species should be compared
with blank samples (control). The lowest concentration
of the sample which is detected and differentiated from
background noise (the blank), is introduced as detection
limit. Signal to noise ratio of 3: 1 or 2: 1 is accepted.
Detection limit is not involved in quantification of
samples. (LOD =Signal /noise)
To determine the quantification limit of method,
according to ICH guidelines, signals for low
concentrations of samples should be compared with
blank samples (control). The lowest concentration which
is reliably determined, is introduced as limit of
quantification. Signal to noise ratio of 10: 1 is considered
as LOQ that enables reasonably recognition of the
concentrations. (LOQ = Signal /noise)
Proof of selectivity or specificity requires in determining
the amount of impurities with appropriate accuracy and
precision along showing that the process of analysis is
not affected by the presence of impurities. In practice,
this can be achieved by adding raw pharmaceutical
material or product to a mixture of appropriate amounts
Asian Journal of Pharmaceutical Analysis. 10(2): April- June, 2020
72
of impurities and excipients showing that the results of
the quantification are not influenced by the presence of
foreign substances. Selectivity of the method for
determination of hydrocortisone and prednisolone was
evaluated by adding 1ml of 5μg/ml standard solution of
hydrocortisone to 100mg of product powder which is
free of any anti-inflammatory drug. Methanol was added
to bring the volume and the mixture was stirred to be
completely uniform. Then, it was centrifuged for an hour
and the supernatant was tested. This method was
similarly done for prednisolone[35,36].
Three types of powdered cartilage supplements in the
market were tested. 1 g of each sample was extracted
about drug by solvents. The resulting solution was
injected directly into the HPLC system.
RESULTS AND DISCUSSION:
Differences in extractions by the four solvents
represented that both chloroform and acetonitrile do not
show acceptable separated spectra for substances.
Ethanol and methanol both are suitable solvents to
extract both substances but ethanol as a clean, cheap and
safe solvent is preferred (fig.1).
Figure1. The absorption spectra of prednisolone and hydrocortisone
extracted by different solvents: prednisolone extracted by
acetonitrile(A), chloroform(B), methanol(C), ethanol(D) and
hydrocortisone extracted by acetonitrile(E), chloroform(F),
methanol(G), ethanol (H).
The column (C18, 250mm, 4.5mm and 10μm) from
Thames Restek Ltd UK was used to find optimum
conditions. According to previous studies, water-
methanol mobile phase in gradient mode was used at
first. Prednisolone and hydrocortisone peaks were
appeared separately in this condition. Since the peaks
had low height, the reproducibility of results was not
observed in subsequent injections declaring that this type
of mobile phase is not appropriate to identify
prednisolone and hydrocortisone by this method[36,37]. At
this stage, due to the chemical nature of species and
instrumental conditions, the mobile phase mixture was
changed to water: acetonitrile. Therefore, different
percentages of the two solvents were studied and ratios
of 45:55 and 55:45 (reducing the amount of acetonitrile
and increasing the percentage of water) were analyzed. It
was observed that by increasing the percentage of
aqueous solvent, the retention time for hydrocortisone
and prednisolone increases; while by reducing the
percentage of organic solvent, the retention time, the
area under the peak and the resolution of peaks are
optimal. Thus 45% of acetonitrile according to tests was
carried out. Chromatograms related to the ratios of
mobile phase for prednisolone and hydrocortisone
standards are showed in figure 2. The best ratio of the
two solvents, according to the parameters of retention
time and peak area was selected 55:45 (water:
acetonitrile).
Figure2. Standard chromatogram of prednisolone and hydrocortisone
in different ratios of solvents: Standard chromatogram of prednisolone
in mobile phase with the ratio of water: acetonitrile 65: 35(A),
Standard chromatogram of hydrocortisone in mobile phase with the
ratio of water: acetonitrile 65: 35(B), standard chromatogram of
prednisolone in mobile phase with the ratio of water: acetonitrile 55:
45(C), standard chromatogram of hydrocortisone in mobile phase with
the ratio of water: acetonitrile 55: 45(D).
As regards a decrease in retention time depends on the
sample and the mobile phase, the results for effect of
rising the temperature on retention time of
hydrocortisone and prednisolone standards showed that
the best column temperature for analyzing the samples is
30 °C. The effect of rising the column temperature was
Asian Journal of Pharmaceutical Analysis. 10(2): April- June, 2020
73
also tested on the area under the peak and it was found
that the column temperature has no effect.
Chromatograms of standard concentrations of drugs in
30°C column temperature are shown in figure 3.
Figure3. Chromatograms of prednisone and hydrocortisone standards
in different column temperatures: Chromatograms of prednisolone
standard in column temperature of 30°C (A), Chromatograms of
hydrocortisone standard in column temperature of 30°C (B),
Chromatograms of prednisolone standard in column temperature of
40°C (C), Chromatograms of hydrocortisone standard in column
temperature of 40°C (D).
As a result of the study of retention time and acceptable
peak shape, optimum flow rate was determined 1ml/min.
Average area under the peak and retention times for
drugs are depicted in table 2.
Table2.Evaluation of retention time and area under the peak for
drugs in different flow rates
Area under the peak
Retention time
(min)
0.9
1
1.1
0.9
1
1.1
Flow rate
(ml/min)
27.32
25.26
10.88
4.37
3.28
3.55
Prednisolone
75.06
69.52
61.33
9.65
6.52
7.55
Hydro
-cortisone
Maximum absorption for prednisolone and
hydrocortisone was observed at about 250 nm. Using
UV detector in wavelengths of 250 and 260 nm for
detection of hydrocortisone and prednisone standards
showed similar reduction in the area under the peak than
254 nm. According to the results (table 3), a wavelength
of 254 nm is desirable because the retention time and
area under the peak are desirable and there is no
interference between sample and solvent.
Table3. Evaluation of retention time and area under the peak for
drugs in different Wavelengths
Area under the peak
Retention time
(min)
260
254
250
260
254
250
Wavelength
(nm)
342.5
518.7
285.3
4.3
3.9
4.2
Prednisolone
581.1
654.6
521.1
8.9
8.4
9.1
Hydro
-cortisone
Standard calibration curve of prednisolone was plotted
using standard solutions in the range of 7 to 13μg /ml.
Standard calibration curve of hydrocortisone was plotted
using standard solutions in the range of 70 to 130μg/ml.
The manner and linearity of the calibration curves with
the deviation of points of R> 0.99 represents a linear
correlation for the method in used concentrations (fig.4).
Figure4. Calibration curve and linearity evaluation for prednisolone
(A) and hydrocortisone (B) assay
Standard solutions of hydrocortisone and prednisolone
were injected into HPLC system to study precision of
within day (intra-day) and between days (inter-day)
working. The results were arranged in table4.
Asian Journal of Pharmaceutical Analysis. 10(2): April- June, 2020
74
Table 4. Results of within day and between day precision study for prednisolone and hydrocortisone: intra-day precision study for
prednisolone (A), hydrocortisone (B), inter-day precision study for prednisolone (C), hydrocortisone (D)
Concentration
(µg/ml)
AUC
Sample 1
AUC
Sample 2
AUC
Sample 3
RSD%
Sample 1
Sample 2
Sample 3
20
25.290
24.381
24.535
First
day
0.074
0.069
0.038
20
25.288
24.319
24.695
Second day
0.092
0.058
0.032
20
25.257
24.407
24.696
Third day
0.083
0.063
0.023
Mean
25.278
24.369
24.642
Mean
RSD%
0.083
0.063
0.031
SD
0.019
0.168
0.093
RSD%
0.074
0.689
0.377
A
C
B
D
Concentration
(µg/ml)
AUC
Sample 1
AUC
Sample 2
AUC
Sample 3
RSD%
Sample 1
Sample 2
Sample 3
100
69.721
72.282
69.463
First day
0.023
0.090
0.058
100
69.393
72.423
69.545
Second day
0.031
0.095
0.060
100
69.140
72.374
69.502
Third day
0.027
0.011
0.062
Mean
69.711
72.354
69.503
Mean
RSD%
0.027
0.069
0.060
SD
0.016
0.066
0.041
RSD%
0.023
0.090
0.058
Standard solutions of two drugs with different
concentrations in the linear range were injected into the
HPLC system. Accuracy was determined by the recovery
percentage of species. The obtained results were located
in the range of 97% -103% (table 5).
Table 5. Results of accuracy verification for prednisolone (A) and
hydrocortisone (B) standards
Concentration
(µg/ml)
A
Recovery percent
(% R)
Peak area
Mean
8
38.630
38.599
100.07
8
38.658
8
38.511
11
55.259
55.353
101.05
11
55.488
11
55.277
Concentration
(µg/ml)
B
Recovery percent
(% R)
Peak area
Mean
90
39.292
39.158
102.09
90
39.129
90
39.054
110
47.451
47.635
100.01
110
47.569
110
47.885
The lowest concentrations of standard solutions of
prednisolone and hydrocortisone were identified and
detected equal to 0.001μg/ml and 0.02μg/ml,
respectively. Signal to noise ratios for prednisolone and
hydrocortisone in mentioned concentrations were
calculated 5.55 and 3.09, respectively, that are in the
acceptable range of 3 and 10. The lowest
concentrations of prednisolone and hydrocortisone
standards were measured equal to 0.01μg/ml and
0.2μg/ml, respectively. Signal to noise ratios for
prednisolone and hydrocortisone in mentioned
concentrations were calculated 12 and 16, respectively,
that are in the acceptable range of ≥ 10.
Solutions resulted from the extraction processes were
injected into the HPLC system, and at wavelength of
254nm two peaks related to prednisolone and
hydrocortisone were appeared. Chromatograms obtained
from analyzing standard solutions of hydrocortisone and
prednisolone, cartilage supplements without
hydrocortisone and prednisolone (placebo) and cartilage
supplements containing hydrocortisone and prednisolone
(Spiked) at the wavelength of 254nm showed that the
two drugs can be separated by a resolution coefficient of
>3 and do not interfere with other ingredients (fig.5).
Figure 5. Results for analyzing supplements at 254 nm to study
specificity of the method: standard solution of prednisolone (A),
cartilage supplement without prednisolone (B), cartilage supplement
containing prednisolone (C), standard solution of hydrocortisone (D),
cartilage supplement without hydrocortisone (E), cartilage supplement
containing hydrocortisone (F).
Asian Journal of Pharmaceutical Analysis. 10(2): April- June, 2020
75
Analysis of real samples of cartilage supplements
(bone-building supplements):
Three cartilage repair supplements were analyzed by
described HPLC procedure at the wavelength of 254nm
to examine whether the claims on the labels of these
supplements that are free of any chemical compounds,
are true or not. Chromatograms derived from the
supplements at 254nm are shown in Figure 6.
Figure 6. Chromatograms obtained from the analysis of real samples
of cartilage repair supplements in the market (Glucosamine capsules)
for prednisolone and hydrocortisone
According to the chromatograms, to determine the
amount of active ingredients of prednisolone and
hydrocortisone in three glucosamine capsule samples,
the average area under the curve of prednisolone and
hydrocortisone in real sample solutions, were determined
and the amount of the compounds found in each sample
was calculated using calibration line equation and
reported in µg/g value (table 6).
Table 6. The results for assay of prednisolone and hydrocortisone
in three samples of glucosamine capsule in the market
Corticosteroid
Sample A
(µg/g)
Sample B
(µg/g)
Sample C
(µg/g)
Prednisolone
0.27
0
0.25
Hydrocortisone
2.37
0.59
1.04
This study aimed to achieve an optimal HPLC method to
identify and quantify the anti-inflammatory compounds
(prednisolone and hydrocortisone) in cartilage repair
products. According to research done, parameters such
as column type, the wavelength of detector, the
percentage of each solvent in mobile phase, column
temperature, flow rate and injection volume for the
analysis of prednisolone and hydrocortisone were
optimized. Optimum conditions of parameters are
presented in the table 7.
Table 7. Optimum values for analysis of prednisone and
hydrocortisone by HPLC method
Optimized condition
Parameters influencing in the
analysis
C18: 25cm/4.5 mm/10µm
Column: length/diameter/stationary
phase particles diameter
254 nm
Wave length of detector
water: acetonitrile 55: 45
Mobile phase
30oC
Column temperature
1 ml/min
Flow rate
20 µl
Injection volume
CONCLUSION:
In this study an HPLC analysis method for determination
of the amount of corticosteroids (prednisolone and
hydrocortisone) in cartilage repair supplements was
tested. The method is simple, rapid, selective, affordable
and valid. The method of extraction and sample
preparation are simple and fast as well as the method is
highly efficient. The method showed acceptable
accuracy and precision in an appropriate linearity range
therewith low detection and quantification limits, for the
analysis of corticosteroids in cartilage repair
supplements. In this method, the matrix of supplements
(excipients) does not interfere to the evaluation of
corticosteroids. The developed method was accepted as a
valid applicable instruction for evaluation of
corticosteroids in cartilage repair products and validated
as a Standard Operating Procedure (SOP) by Iran
Reference Food and Drug Control Laboratories. As a
result, evaluation of cartilage repair (bone-building)
supplements that are imported to the country and
estimation of products infected with corticosteroids is
accomplished by this method. This work is the first study
done toward the assessment of dietary cartilage repair
(bone-building) supplements regarding to the
determination of corticosteroids.
ACKNOWLEDGEMENT:
This work was supported by Iran Food and Drug Control
Laboratories by the equipment and materials but it did
not receive any grant from funding agencies in the
public, commercial, or not-for-profit sectors.
CONFLICT OF INTEREST:
The authors announce that there is no conflict of interest
about article.
Asian Journal of Pharmaceutical Analysis. 10(2): April- June, 2020
76
REFERENCES:
1. Blumberg, JB, et al., The evolving role of multivitamin/
multimineral supplement use among adults in the age of
personalized nutrition; Nutrients, 2018, 10: 2.
2. Better Health Channel, “Hormones cortisol and corticosteroids,”
pp. 13. https://www.betterhealth.vic.gov.au/health/ conditionsand
treatments/Hormones-cortisol-and-corticosteroids? View AsPdf=
true.
3. Hazen, R., Strategic Nutrition for healthy aging, fortitech
premixes, 2014, DSM March: 112.
4. Becker, DE., Basic and clinical pharmacology of
glucocorticosteroids., Anesth. Prog., 2013,60 (1): 2531.
5. Karankumar V. Biradar and Amit Pawar, Corticosteroids and way
of inflammation, Research J. Pharmacology and
Pharmacodynamics; 4 (1): 2012; 45-54.
6. Dhole A R., et al., Drug used in Inflammatory Bowel Disease
(IBD)-Brief Review, Research Journal of Pharmacology and
Pharmacodynamics. 6(3): July- September, 2014, 153-161
7. Maurya, P R., Joshi, Y M., Kadam, V J., A Review on Bronchial
asthma, Research J. Pharmacology and Pharmacodynamics; 5(4):
2013;257-265.
8. Mckay, LI., Cidlowski, JA., Physiologic and Pharmacologic
Effects of Corticosteroids, In: Kufe DW, Pollock RE,
Weichselbaum RR, et al., editors. Holland-Frei Cancer Medicine.
6th edition. Hamilton (ON): BC Decker, 2003.
9. Klein, GL., The effect of glucocorticoids on bone and muscle,
Osteoporos. Sarcopenia, (2015); 1 (1): 39-45.
10. Macfarlane, DP., Forbes, S., Walker, BR., Glucocorticoids and
fatty acid metabolism in humans: Fuelling fat redistribution in the
metabolic syndrome, J. Endocrinol., 2008, vol. 197 (2): 189204.
11. Buchman, AL., Side effects of corticosteroid therapy, J. Clin.
Gastroenterol., 2001,33 (4): 289294.
12. Halpern AA., Horowitz, BG., Nagel, DA, Tendon ruptures
associated with corticosteroid therapy, West. J. Med.,1977,127(5):
37882.
13. Halle, ZB., Etiology of Peptic Ulcer Disease, Peptic Ulcer Disease,
2016,4: 111.
14. Shekhar, J., Mandapati, R., Metta, A. K., Intraocular pressure
variation in patients on long-term corticosteroids, Ind. Derm.
Online J., 2011,2 (2): 6769.
15. Sarumathy S., et al., Clinical Comparison of the Efficacy and
Safety of Intra-Articular Injections of Sodium Hyaluronate and
MethylPrednisolone in the Treatment of Osteoarthritis of Knee,
Research J. Pharm. and Tech. 8(11): November 2015.
16. Kunithala V K. , et al., Phase -1 Clinical Trials on Formulation and
Evaluation of Colon Specific Methylprednisolone Matrix Enteric
Coated Tablets, Research J. Pharm. and Tech. 5(7): July 2012.
17. Garala, R.J., et al., Colon Targeted Drug Delivery System of
Prednisolone by Press Coating Technique: Effect of Different
Grades of Hydroxyethylcellulose in Coat, Research J. Pharm. and
Tech. 4(3): March 2011.
18. Clegg, DO. et al., Glucosamine, Chondroitin Sulfate, and the Two
in Combinationfor Painful Knee Osteoarthritis, New England
Journal, 2006, 354(8), 795808.
19. Da Camara, CC., Dowless, GV., Glucosamine sulfate for
osteoarthritis, Ann. Pharmacother., 1998, 32 (5) : 580587.
20. U.S Food and Drug Administration, “Dietary Supplements,” Food
facts, 2017, 5: 12.
21. Chitlange S S., et al., UV Spectroscopic and Stability-Indicating
TLC- Densitometric Method for Simultaneous Estimation of
Salbutamol sulphate and Prednisolone in Pharmaceutical Dosage
Form, Asian J. Research Chem. 4(5): May, 2011.
22. Kulkarni, P A. Kasture, P V., Spectrophotometric Simultaneous
Estimation of Salbutamol and Prednisolone in Bulk and
Formulation, Asian J. Research Chem. 4(4): April, 2011.
23. Van Thuyne, W., Delbeke, FT., Validation of a GC-MS Screening
Method for Anabolizing Agents in Aqueous Nutritional
Supplements, J. Chromatogr. Sci., 2005,43(1): 26.
24. Ionita, IA., Fast, DM., Akhlaghi, F., Development of a sensitive
and selective method for the quantitative analysis of cortisol,
cortisone, prednisolone and prednisone in human plasma, J.
Chromatogr. B Anal. Technol. Biomed. Life Sci., 2009; 877(89):
765772.
25. Sianos, CE., et al., Detection of 23 Corticosteroids, Anabolic
Steroids, and ß2-Agonist in Athens Doping Control Lab, During
Athens 2004 Olympic Games Using Agilent 1100 LC / MSD Trap
Mass Spectrometers Application, 2004.
26. Matabosch, X., et al., Detection and characterization of
prednisolone metabolites in human urine by LC-MS/MS, J. Mass
Spectrom., 2015, 50(3): 633642.
27. Siddiraju, S., Lal Prasanth, ML., Sirisha, T., A novel LC-MS/MS
assay for methylprednisolone in human plasma and its
pharmacokinetic application, Asian J. Pharm. Sci., 2016, 11 (3):
459468.
28. Mcwhinney, BC., et al., Measurement of cortisol, cortisone,
prednisolone, dexamethasone and 11-deoxycortisol with ultra high
performance liquid chromatography-tandem mass spectrometry:
Application for plasma, plasma ultrafiltrate, urine and saliva in a
routine laboratory, J. Chromatogr. B Anal. Technol. Biomed. Life
Sci., 2010, 878 (28):28632869.
29. Panusa, A., et al., A rapid and sensitive LC-ESI-MS/MS method
for detection and quantitation of methylprednisolone and
methylprednisolone acetate in rat plasma after intra-articular
administration, J. Pharm. Biomed. Anal., 2010, 51(3): 691697.
30. Djedovic, NK., Rainbow, SJ., Detection of synthetic
glucocorticoids by liquid chromatography-tandem mass
spectrometry in patients being investigated for cushing’s
syndrome, Ann. Clin. Biochem., 2011, 48(6): 542549.
31. Shibasaki, H. et al., Simultaneous determination of prednisolone,
prednisone, cortisol, and cortisone in plasma by GC-MS:
Estimating unbound prednisolone concentration in patients with
nephrotic syndrome during oral prednisolone therapy, J.
Chromatogr. B Anal. Technol. Biomed. Life Sci., 2008, 870(2):
164169.
32. Gad kariem, E. A. et al., Development and Validation of an RP-
HPLC Method for Estimation of Prednisolone and its Degradation
Products in Tablets, EC Pharm. Sci., 2016,3: 312324.
33. Rubio, CP., et al., Validation of an automated assay for the
measurement of cupric reducing antioxidant capacity in serum of
dogs, BMC Vet. Res., 2016,12 (1): 411.
34. Hart, DJ., Scott, KJ., Development and evaluation of an HPLC
method for the analysis of carotenoids in foods, and the
measurement of the carotenoid content of vegetables and fruits
commonly consumed in the UK, Food Chem., 1995, 54 (1): 101
111.
35. Souri, E., Jalalizadeh, H., Saremi, S., Development and validation
of a simple and rapid Hplc method for determination of
pioglitazone in human plasma and its application to a
pharmacokinetic study, J. Chromatogr. Sci., 2008, 46(9): 809812.
36. Bhat, LR., et al., Validated RP-HPLC method for simultaneous
determination of Telmisartan and hydrochlorothiazide in
pharmaceutical formulation, J. Liq. Chromatogr. Relat. Technol.,
2007, 30(20) 30593067.
37. Muñiz-Valencia, R. et al., Method development and validation for
melamine and its derivatives in rice concentrates by liquid
chromatography. Application to animal feed samples, Anal.
Bioanal. Chem., 2008, 392 (3):523531.
38. Irakli, MN., et al., Development and validation of an HPLC-
method for determination of free and bound phenolic acids in
cereals after solid-phase extraction, Food Chem., 2012, 134 (3):
16241632.
39. Revathi R., et al., RP-HPLC Analysis for Quantitation of
Candesartan Cilexetil in Solid Dosage Forms, Asian J. Pharm.
Ana. 2013; Vol. 3: Issue 4, Pg 115-118.
40. Jaiswal Y S. et al., Isolation and Quantitative Analysis of a
Bioactive Polyphenol - Catechin in Anacardium occidentale Linn.
(Leaves and Testa) by HPLC Analysis, Research J.
Pharmacognosy and Phytochemistry 2010; 2(5): 372-376.
... There are many different methods for determining these materials using chromatography (Razi et al. 2020), electrochemical (Primpray et al. 2019), near-IR (Vakili et al. 2017), capillary electrophoresis (Kravchenko et al. 2021), and so on. Due to their high sensitivity, liquid chromatographytandem mass spectrometry (LC-MS/MS) (Wu et al. 2019;Beguiristain et al. 2019;Lamy et al. 2020) and gas chromatography (Chong et al. 2021) are often used in different analytical methods reported for corticosteroids. ...
Article
The current review summarized the progress that has been made over the years for the colorimetric determination of corticosteroids using chromophore reagents. Following an introduction to the subject and the fundamentals of colorimetric detection of corticosteroids, the chromophoric reagents were described in detail, and a perspective on the future of these materials was proposed. Different chromophores and various colorimetric reactions used for the detection of corticosteroids in real samples were reviewed. The key point of this review is to investigate and collect the colorimetric methods to improve the sensors based on image analysis, wearable sensors, and smartphones for corticosteroids in the future.
Article
Background and Aim Lincomycin is an antibiotic used in broiler farming and is commonly combined with other substances to achieve synergistic and complementary effects on the antibacterial spectrum and mechanism. We developed a specific high-performance liquid chromatography (HPLC) method to measure lincomycin levels in broiler tissues. This study aimed to determine the lincomycin level in tissues and compare it with the minimum inhibitory concentration (MIC) and maximum residue limit (MRL) of certain pathogenic bacteria. Materials and Methods Three groups of broiler chickens were involved in the study (n = 20 in each group): A control group without lincomycin treatment and two groups (each further divided into two sub-groups) that received oral lincomycin at a dose of 1 g/10 kg of body weight daily for 7 and 14 consecutive days. Tissue samples were collected from each group 1 day and 1 week after lincomycin administration (ALA). This study validated the development of a technique for analyzing drug level degradation in tissues using HPLC. Descriptive and statistical analyses were performed for drug levels to assess their therapeutic value and safety based on lincomycin MIC of certain pathogenic bacteria and MRL. Results The method validation resulted in linear regression and coefficient of determination for tissues with r² > 0.99, with a recovery rate of 90%–110%, precision as the coefficient of variation 15%, and specificity with no peak overlap for lincomycin. The limits of detection for the liver and kidney were 0.01 μg/g, 0.05 μg/g, and 0.1 μg/g for the breast muscle and all tissues. Administration of lincomycin for 7 and 14 days resulted in therapeutic value concentrations. Lincomycin levels in the liver and kidney of ALA exceeded the MRL, whereas breast muscles were below the MRL for a week of ALA treatment. Conclusion Administration of lincomycin for 7 and 14 consecutive days resulted in therapeutic value; however, after a week, most tissues showed high drug concentrations that exceeded the MRL. It is necessary to carefully consider the prolonged therapeutic dose of lincomycin in broilers. Antibiotic therapy must be guided in such a way as to protect the product from harmful residues.
Article
A modest and swift microwave-backed extraction process has been established for the abstraction of a flavonoid mangiferin from the Shoot bark of Mangifera indica L. The content in the extracts was quantified by planar chromatography. An orthogonal array strategy was employed to conclude the effects of variables that affect the efficiency of MAE, namely temperature, irradiation period, the clout of irradiation, and particle size of drug powder. Under optimal conditions, MAE showed expressively higher recovery of mangiferin and markdown in the extraction period as well as solvent intake in comparison to the conventional method.
Article
The study was carried out to prepare, characterize, and investigates the pharmacological evaluation of Bauhinia variegata lauha bhasma (BVLB). The Lauha bhasma (LB) was prepared according to the reported standard method that involved the destruction of metallic state followed by conversion of crude product into bhasma state. The purification was done using Triphala extract prepared in cow-urine. The destruction of the metallic test was carried out using process juice of BV. At the last, the preparation of BVLB is subjected to a closed crucible system to get the final product. The characterization of BVLB was done by some preliminary examination followed by specific methods viz. X-ray diffractometry (XRD), Infrared (IR) spectroscopy, and UV-visible spectrophotometry. The In-vitro anti-inflammatory, anti-arthritic and antioxidant activity was carried out for BVLB at different concentrations of 50, 100, 200, and 250μg/mL. The said In-vitro activities were screened using percent inhibition of heat-induced hemolysis, the percent inhibition of protein denaturation, proteinase inhibition, and DPPH free radical scavenging activity. BVLB preliminary investigation showed 1.53 % aqueous and 3.95 % HCL solubility whereas specific characterization methods showed the formation of micro and nanocrystals of F2CO3. The BVLB showed % inhibition of hemolysis of in between 5.26 ± 0.95 to 31.20±4.12 whereas percent inhibition of protein denaturation in between 12 ± 1.22 to 52.22 ± 4.69. The percent proteinase inhibition of BVLB at a different concentration from 50, 100, 200, and 250μg/mL was estimated and found in between 3.26 ± 0.86 to 51.22 ± 3.12. The free radical scavenging activity of BVLB was found from 10.11 1 ± 0.89 to 52.05 ± 2.05. From the current investigation, it can be conducted that BVLB has significant In-vitro anti-inflammatory, anti-arthritic and antioxidant activity. The formed nanocrystals and presence of BV active constituents would be the underlying intermediaries for significant activity.
Article
Drug analysis is crucial in the discovery, production, and therapeutic use of pharmaceuticals. Standard analytical procedures for newer medications or formulations may not be available in Pharmacopoeias; thus, newer analytical methods that are accurate, precise, specific, linear, simple, and rapid must be developed. A rapid, simple, sensitive, precise, and cost-effective RP-UHPLC method was developed and validated for the determination of Teriflunomide Active Pharmaceutical Ingredient (API) in this study. The method involved determination of Teriflunomide by resolving on RP-UHPLC using Sunniest C18 (250mm × 4.6mm, 5μm) column, utilizing a mobile phase of ACN: Water in the ratio of 60:40 v/v. The mobile phase was delivered with an isocratic flow rate of 1.0ml/minute. Ultra violet detection was carried out at 210nm. The retention time was optimized to 4. 4 minutes. The linearity range of Teriflunomide 35 to 247µg/ml was found to obey linearity with a correlation coefficient of 0.999. The LOD and LOQ were found to be 1.61µg/ml and 4.90µg/ml respectively and precision data was found to be <2 %RSD. The percentage recovery range was found to be satisfied which is represented in the results. The robustness studies were performed by changing the flow rate and mobile phase compositions. The method was validated for system suitability, specificity, linearity, precision, accuracy, Limit of Detection, Limit of Quantification and robustness. The developed method can be applied for the quality control of commercial teriflunomide API.
Article
Full-text available
Micronutrient deficiencies occur in segments of the adult population in the United States. Multivitamin/multimineral supplements (MVMS) are widely used by this population, which reduces inadequacies in micronutrient intake, but the potential for exceeding tolerable upper intake levels in others should be considered. There are concerns associated with the excessive intake of certain nutrients, particularly folic acid, and potential untoward consequences. The advent of nutrigenomics and the enhanced ability to directly study the interactions between nutrition and genetic variants and expression will allow for the conduct of more targeted studies with specific endpoints and may ultimately lead to progress in the field of personalized nutrition. The role of MVMS in health maintenance and chronic disease prevention remains controversial. Conducting studies in this area has been hampered by, among other factors, inconsistent definitions of MVMS, ranging from as few as three vitamins to broad-spectrum products containing more than two dozen vitamins and minerals. Results from some observational studies and large-scale, randomized, controlled trials suggest that MVMS may reduce the risk of some forms of cancer and, potentially, cardiovascular disease. The ongoing COcoa Supplement and Multivitamin Outcomes Study (COSMOS) is expected to build on this research and provide additional insights into these areas.
Article
Full-text available
A rapid, accurate and sensitive method for simultaneous determination of salbutamol sulphate (SAL) and prednisolone (PRE) in pharmaceutical dosage form was developed in the present work. The first developed method was an area under curve method, wavelength selected is 232-222nm for salbutamol and 249-239nm for prednisolone respectively. Linearity was observed in concentration range of 6-20μg/ml for salbutamol as well as for prednisolone. The second developed method was high-performance thin layer chromatography (HPTLC). The mobile phase selected was Ethyl acetate: Chloroform: methanol (6.0: 4.0:1.0 v/v/v) with UV detection at 230 nm. Retention factor for SAL and PRE were found to be 0.17 ± 0.02 and 0.52 ± 0.03 respectively. For HPTLC method, linearity was observed in the concentration range of 1-6μg/band for salbutamol and 2-6μg/band for prednisolone and drugs was subjected to oxidation, acid hydrolysis, base hydrolysis and sun light to apply stress condition for degradation studies. Results of the analysis were validated statistically and by recovery studies.(http://www.ajrconline.org/pdf/AJRC_4_5_2011_Abstract.pdf)
Article
Full-text available
Background: The objective of the present study was to optimize and validate an automated method to assess the total antioxidant capacity (TAC) in serum of dogs using the cupric reducing antioxidant capacity (CUPRAC) methodology (TACc) with bathocuproinedisulfonic acid disodium salt as chelating agent, evaluating also possible variations due to the use of two different automated analyzers. The method is based on the reduction of Cu(2+) into Cu(1+) by the action of the non-enzymatic antioxidants that are present in the sample. Results: Imprecision was low in both apparatus utilized, and the results were linear across serial Trolox and canine serum samples dilutions. Lipids did not interfere with the assay; however, hemolysis increased the TACc concentrations. When TACc concentrations were determined in ten healthy (control) dogs and in twelve dogs with inflammatory bowel disease (IBD), dogs with IBD had lower TACc concentrations when compared with the healthy dogs. Conclusions: The method validated in this paper is precise, simple, and fast and can be easily adapted to automated analyzers.
Article
Full-text available
This article examines the current knowledge of the effects of both exogenous and endogenous glucocorticoids on bone and muscle. It demonstrates the similarity of effects of supraphysiologic loads of glucocorticoids regardless of whether they enter the body in the form of medication or are manufactured by the body in response to stimuli such as inflammation. The effects of endogenous glucocorticoids and the systemic inflammatory response resulting from pediatric burn injury are compared and the difficulty in sorting out which of the two factors is responsible for the ultimate effects on bone and muscle is pointed out. The focus then switches to the body's response to the influence of both glucocorticoids and inflammatory cytokines and evidence supporting a common pathway of response to oxidative damage caused by both is discussed. Current recommended medical management of glucocorticoid-induced bone and muscle loss is discussed and the failure to reconcile current management with known mechanisms is highlighted.
Article
Full-text available
sitive and selective liquid chromatography/tandem mass spectrometry (LC–MS/MS) assay for the determination of methylprednisolone applying budesonide as internal standard. Liquid– liquid extraction (LLE) having tert–butyl methyl ether (TBME) have been employed to extract methylprednisolone from the plasma samples. Immediately after reconstitution, the samples were chromatographed on a C18 column using an isocratic mobile phase composed of 10 mM ammonium formate buffer and acetonitrile (35:65, v/v). A flow rate of 1.00 mL/min was used to elute the analyte form the column. Analysis was carried out with an API–4000 LC–MS/ MS instrument operated in multiple reaction-monitoring (MRM) mode. The linearity has been proven within the concentration range of 10.1–804 ng/ml in plasma samples. The precision (%CV) and accuracy results in five validation batches across five concentration levels were well within the acceptance limits. The drug was stable under different conditions. The particular assay has been proficiently put on pharmacokinetic study in healthy male subjects.
Article
The present study described the development of a reversed-phase liquid chromatographic method for the estimation of abiraterone acetate by Quality by Design (QbD) approach. Using an isocratic solvent system for the mobile phase, the chromatographic estimation of analyte was performed on a Hypersil BDS C18 column using mobile phase mixture containing acetonitrile and water with pH adjusted with 0.1% v/v orthophosphoric acid (15:85%v/v ratio), flow rate 1.0 mL.min−1 and detection at 250 nm using photodiode array detector. Systematic development of the chromatographic method was carried out by factor screening using a half-factorial design which suggested organic modifier (%), flow rate (mL.min−1) and autosampler temperature (°C) as influential variables. Further, the method was optimized by Box–Behnken design and trials performed were evaluated for the area under peak, retention time, theoretical plate count and tailing factor as the responses. Validation of the developed method showed good linearity, accuracy, precision and sensitivity. Evaluation of the stability-indicating profile of the method using forced degradation studies revealed the formation of a possible degradation product under acidic and alkaline conditions, while no such degradation product peaks were observed under the oxidative environment. Overall, the study construed the successful development of HPLC assay method for pharmaceutical applications.
Article
The main objective of this study is to determine the safety and efficacy of the intra-articular injections (IA) of Sodium hyaluronate and methylprednisolone in the treatment of osteoarthritis (OA) of knee. The study was carried out in the orthopedic department of a multispeciality hospital for a period of 6 months from November 2013 to April 2014. Total number of 46 patients with OA of knee were categorized into two treatment groups, sodium hyaluronate (Group A, n= 26) and methylprednisolone (Group B, n= 20). Group A and B patients received sodium hyaluronate IA injection once a week for continuous 3 weeks and methylprednisolone IA injection once in 6 months. Pain score was assessed based on VAS (Visual Analogue Scale) and the recordings were done at baseline (1st visit), review 1 (2 weeks after IA injection), review 2 (4 weeks after IA injection) and review 3 (8 weeks after IA injection). ADRs for both the treatment groups were monitored and assessed. Sodium hyaluronate significantly reduced the VAS mean pain score with baseline-6.27, review 1-5.00, review 2-3.96 and review 3-3.15 for Group A patients and baseline-7.79, review 1-6.15, review 2-5.15 and review 3-5.68 for Group B patients. Edema and rashes were seen in Group A patients, similarly, edema and insomnia were seen in Group B patients which was mild to moderate. Sodium hyaluronate was safe and effective for OA of knee when compared with methylprednisolone. © RJPT All right reserved.
Article
Press-coated tablets are able to release the core drug after of lag time and have potential for colon targeted drug delivery based on gastrointestinal transit time concept. This study investigated the factors influencing in vitro release characteristics of model drug prednisolone from press coated tablets. Prednisolone is a poorly water soluble drug having pH-independent solubility. Solubility enhancement of prednisolone with hydroxypropyl β-cyclodextrin (HP β- CD) was studied by phase solubility analysis. HP β-CD increased solubility of prednisolone. Phase solubility studies suggested that 1:2 complex of prednisolone-HP β-CD was formed. A physical mixture of prednisolone and HP β-CD was incorporated in core tablet. The core tablet, prepared by a direct compression method, was designed to disintegrate and release drug quickly. To prepare press coated tablets, 50 % of coating polymer was first, followed by centering the core tablet and compressing with remaining 50 % of the coating polymer. Effect of Natrosol viscosity grades (Natrosol L, M and HHX), weight of Natrosol coating, different weight ratios of Natrosol-HHX: Natrosol M and different weight ratios of Natrosol-L: Natrosol M on the lag time of drug release was studied. The lag phase was markedly dependent on the weight ratios of Natrosol-HHX: Natrosol M or Natrosol-L: Natrosol M in coat. Larger coating weight of Natrosol M produced larger coating thickness around core tablet, which resulted in increased lag time and decreased drug release. Different lag times of the press-coated tablets from 2 to 9.5 hours could be modulated by changing the type and amount of Natrosol. Natrosol of higher viscosity (Natrosol HHX) provide better protection of the drug containing core, showing increased lag time and slower drug release. Incorporating low viscosity polymer (Natrosol-L) in coat leads to decrease in lag time and rapid drug release. The results indicate that Natrosol M coated tablet formulation is more suitable for transit (5.5 hrs) through stomach and small intestine and faster release of drug in colon.
Article
The purpose of the present investigation is to develop a new simple method to target a colon specific site, methylprednisolone type low dose drugs can be protect from it disintegration and drug release than reached the colon site by using matrix enteric coated technique, microsomal degradation pectin, and pH sensitive Eudragit S100 polymers have capability to retard the drug release and show sustain release in the upper gastro intestinal system than progressively fast release in the colon. The prepared matrix enteric coated methylprednisolone tablets were optimized using invitro studies, and evaluated for colonic delivery by in vivo x-ray imaging study in human volunteers showed that the tablets reached the colon without disintegrating in the upper GI system and pharmacokinetic studies in healthy humans. The optimized formulation methylprednisolone showed 6.1±0.2 (negligible release) in the initial lag period of 5 h followed by progressive release up to 99.1±0.4 % for 24 h respectively. The C max of colon targeted matrix enteric coated tablets was 9871.42 ng/ml at T max 10hr for metylprednisolone, Differential scanning calorimetry and Fourier Transform Infrared Spectroscopy studies revealed that there was no interaction between drug and polymer and the accelerated stability studies showed the stability of formulation, Thus development of matrix enteric coated tablets was suitable to target the methylprednisolone to colon and treat ulcerative colitis with the conformation of phase 1 trials.
Article
Glucocorticosteroids are prohibited in sports when used by systemic administrations (e.g. oral), whereas they are allowed using other administration ways. Strategies to discriminate between administrations routes have to be developed by doping control laboratories. For this reason, the metabolism of prednisolone (PRED) was studied using liquid chromatography coupled to tandem mass spectrometry. A single oral (10 mg) dose of PRED was administered to two healthy male volunteers. Urine samples were collected up to 6 days after administration. Samples were hydrolyzed with β-glucuronidase and subjected to liquid-liquid extraction with ethyl acetate in alkaline conditions. The extracts were analyzed by liquid chromatography coupled to tandem mass spectrometry. Precursor ion scan methods (m/z 77, 91, 105, 121, 147 and 171) in positive ionization and neutral loss scan methods (76 and 94 Da) in negative ionization modes were applied for the open detection of PRED metabolites. Using these methods, PRED parent compound plus 20 metabolites were detected. PRED and 11 metabolites were characterized by comparison with standards of the compounds (PRED, prednisone, 20β-dihydro-PRED and 20α-dihydro-PRED, 20β-dihydro-prednisone and 20α-dihydro-prednisone, 6β-hydroxy-PRED and 6α-hydroxy-PRED, 20β isomers and 20α isomers of 6β,11β,17α,20,21-pentahydroxypregnan-1,4-diene-3-one, 6α,11β,17α,20β,21-pentahydroxypregnan-1,4-diene-3-one and Δ(6) -PRED). Using mass spectrometric data, feasible structures were proposed for seven of the remaining nine detected metabolites, including several 6-hydroxy-metabolites. Eleven of the characterized metabolites have not been previously described. Maximum excretion rates for PRED metabolites were achieved in first 24 h; however, most of the metabolites were still detectable in the last collected samples (day 6). Copyright © 2015 John Wiley & Sons, Ltd. Copyright © 2015 John Wiley & Sons, Ltd.